Men’s Experiences of PSA Testing and Prostate Cancer in Worcestershire - Follow‑Up Report
Download (PDF 1.36 MB)Summary of report content
Healthwatch Worcestershire worked with the Worcestershire Prostate Cancer Support Group to survey men over the past two years to monitor progress in prostate cancer diagnosis across Worcestershire. This latest survey, carried out in January/February 2026, captures the views of 154 Worcestershire men on PSA testing and prostate cancer. It explores whether experiences have improved.
While some men report positive experiences of prostate cancer care, this report highlights ongoing variation in advice, access and information. It shows that, for some men, challenges remain around later diagnosis, early identification and clarity of information, reinforcing the need for more consistent, risk-based approaches across Worcestershire.
Key findings
Among respondents who knew their diagnosis stage, 43% were diagnosed at Stage 3–4. Some men also described delays, uncertainty about when to seek help, or difficulty accessing follow-up support.
Some higher‑risk respondents reported having to push for testing or seek private options. Risk factors such as family history, ethnicity and age are not consistently leading to earlier testing or proactive support.
Many respondents said PSA testing was prompted by personal concern, family/friends or awareness campaigns. This suggests that awareness and self‑advocacy play a key role in accessing testing, which may disadvantage men with lower awareness.
Experiences of GP support vary, with 45% reporting difficulty, delay or discouragement when discussing prostate concerns. Some men described being refused or discouraged from testing, while others reported positive and supportive care.
Some men reported not receiving clear information about PSA testing, raised results or what happens next. Gaps in information may affect confidence, decision‑making and timely help‑seeking.